Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Subjects With Dry Eye.
Status:
Not yet recruiting
Trial end date:
2024-03-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the safety and efficacy of BRM421 OS to vehicle for
the treatment of the signs and symptoms of dry eye disease.